05/02/2026
When women are underrepresented in clinical trials, data gaps follow.
From safety signals to dosing and outcomes, incomplete representation limits how well results translate to real-world populations.
At Rasai Research, our community-based model supports more inclusive enrollment—strengthening data quality and clinical relevance from the start.